Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1)
N Engl J Med, 2022
Tirzepatide produced mean weight reductions of 15-22.5% at 72 weeks across dose groups vs 3.1% with placebo
Content reviewed by clinical research staff
Evidence graded using the PeptideScholar A-D system.
Tirzepatide is the first dual GIP and GLP-1 receptor agonist, approved by the FDA for type 2 diabetes (Mounjaro) and chronic weight management (Zepbound). Achieves unprecedented weight loss in clinical trials.
Simultaneously activates GIP and GLP-1 receptors, enhancing insulin secretion, reducing glucagon, slowing gastric emptying, and reducing appetite. The dual agonism provides additive metabolic benefits.
This content is for informational purposes only and does not constitute medical advice.
The dosing information above is sourced from published research literature and clinical trials. These are not recommendations. Individual responses vary. Always consult a healthcare provider before considering any peptide-based therapy.
Tirzepatide is FDA-approved and available by prescription. Licensed telehealth providers can evaluate if it's right for you.
Get the Provider ChecklistStart with the evidence and provider checklist while routing is offline.
PeptideScholar may receive compensation from provider referrals. This does not influence our editorial content.
Tirzepatide is currently modeled on this site as an approved treatment path for: Type 2 diabetes mellitus; chronic weight management in adults with obesity or overweight with comorbidities. Brand names in the current dataset: Mounjaro, Zepbound.
Use the reviewed cost hub before you commit to a provider path or a self-pay workflow.
Open cost guide ->Validate reminder, refill, and symptom-tracking demand before the full PWA launches.
Open tracker landing ->Approved product paths, real cost friction, provider routing, and tracker next steps — all in one source-backed hub.
Open treatment hub →N Engl J Med, 2022
Tirzepatide produced mean weight reductions of 15-22.5% at 72 weeks across dose groups vs 3.1% with placebo
N Engl J Med, 2021
Tirzepatide at all doses was superior to semaglutide 1 mg for HbA1c reduction and weight loss
The Peptide Protocols Handbook
Evidence-based reference guide covering mechanisms, research, and clinical applications.
View on AmazonThird-Party Peptide Testing
Independent lab analysis to verify peptide purity and authenticity.
Learn MoreLinks may be affiliate links. See our disclosure.
Products to help manage side effects and optimize outcomes during treatment.
LMNT Electrolyte Packets
Sodium-focused electrolytes to prevent dehydration and fatigue common in early GLP-1 therapy.
High-Protein Shakes (30g)
Convenient protein shakes to maintain muscle mass on reduced GLP-1 caloric intake.
Metamucil Fiber Supplement
Soluble fiber powder to manage constipation and GI side effects during GLP-1 treatment.
Vitamin B12 (Methylcobalamin 1000mcg)
GLP-1 agonists can reduce B12 absorption over time — methylcobalamin is the most bioavailable form.
Ginger Chews for Nausea
Natural nausea relief for the dose-escalation adjustment period, particularly weeks 1–4.
Unflavored Whey Protein Isolate
Preserve lean mass without excess carbs or calories when appetite is suppressed.
Amazon affiliate links; we may earn a small commission at no extra cost to you. See our disclosure.
Monitor weight, body composition, and nutrition to maximize results.
Smart WiFi Body Scale
Tracks BMI, body fat %, and muscle mass — essential for monitoring GLP-1 progress over time.
Digital Kitchen Food Scale
Precise gram-level portion tracking helps maximize weight loss results on GLP-1 therapy.
Protein Shaker Bottle Set
Leak-proof mixing bottles for protein shakes — supports consistent protein intake on a smaller appetite.
Amazon affiliate links; we may earn a small commission at no extra cost to you. See our disclosure.
Books covering peptide science, longevity research, and biohacking frameworks.
The Peptide Protocols
Comprehensive reference for peptide mechanisms, dosing research, and clinical applications.
Boundless by Ben Greenfield
Covers peptides, nootropics, hormones, and longevity strategies in an optimization framework.
Lifespan by David Sinclair
Evidence-based deep-dive into aging science, directly relevant to longevity peptide research.
The Longevity Paradox
Gut-centric aging research with diet and supplementation protocols for extending healthspan.
Amazon affiliate links; we may earn a small commission at no extra cost to you. See our disclosure.
Medical Disclaimer
This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations.
Always consult a qualified healthcare provider before starting, stopping, or modifying any treatment. Do not disregard professional medical advice based on information found on this site.
No claims of therapeutic efficacy are made for substances that are not FDA-approved for the discussed indications. Research citations reflect published findings and do not imply endorsement.